| In Our Practice Psychotherapy Private Practice | |
|
3400 Shattuck Rd Ste 2 Saginaw MI 48603-3157 | |
| (989) 272-3727 | |
| (989) 355-0447 |
| Full Name | In Our Practice Psychotherapy Private Practice |
|---|---|
| Speciality | Social Worker |
| Location | 3400 Shattuck Rd Ste 2, Saginaw, Michigan |
| Authorized Official Name and Position | Stacy Lynn Athens (SOLE MEMBER) |
| Authorized Official Contact | 9892723727 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| In Our Practice Psychotherapy Private Practice 3400 Shattuck Rd Ste 2 Saginaw MI 48603-3157 Ph: (989) 272-3727 | In Our Practice Psychotherapy Private Practice 3400 Shattuck Rd Ste 2 Saginaw MI 48603-3157 Ph: (989) 272-3727 |
| NPI Number | 1124666714 |
|---|---|
| Provider Enumeration Date | 12/15/2019 |
| Last Update Date | 02/16/2022 |
| Certification Date | 02/16/2022 |
| Medicare PECOS PAC ID | 5193135218 |
|---|---|
| Medicare Enrollment ID | O20201030002437 |
News Archive
Major depression, which afflicts one in six people at some point in their life, is the leading global cause of disability - surpassing cardiovascular and respiratory diseases, cancer and HIV/AIDS combined.
BioCancell, a developer of anti-cancer drugs, announced success in attaining the goals of its Phase I/IIa clinical trial of BC-819 as a treatment for pancreatic cancer, which demonstrated an excellent safety profile and preliminary efficacy.
Kaiser Health News staff writer Jenny Gold writes about legislation to repeal this exemption. "With comprehensive health care legislation foundering in Congress, the House is turning to a narrower piece of legislation that lawmakers hope has widespread, populist appeal: repealing the antitrust exemption for health and medical liability insurers.
Althea Technologies, Inc., a leading provider of development and manufacturing services for biopharmaceutical products announced the addition of customized Formulation Development to the company's platform of services, which will be overseen by the newly appointed Dr. James Matsuura, Director of Formulation Development.
CryoLife, Inc., an implantable biological medical device and cardiovascular tissue processing company, announced today its results for the second quarter of 2010. Revenues for the second quarter increased 4 percent to a second quarter record of $29.3 million compared to $28.2 million for the second quarter of 2009. Net income for the second quarter of 2010 was $2.9 million, or $0.10 per basic and fully diluted common share, compared to $2.5 million, or $0.09 per basic and fully diluted common share, for the second quarter of 2009.
› Verified 9 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124666714 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | (* (Not Available)) | Primary |
| Provider Name | Stacy Athens |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1205369626 PECOS PAC ID: 2466738679 Enrollment ID: I20170424000732 |
News Archive
Major depression, which afflicts one in six people at some point in their life, is the leading global cause of disability - surpassing cardiovascular and respiratory diseases, cancer and HIV/AIDS combined.
BioCancell, a developer of anti-cancer drugs, announced success in attaining the goals of its Phase I/IIa clinical trial of BC-819 as a treatment for pancreatic cancer, which demonstrated an excellent safety profile and preliminary efficacy.
Kaiser Health News staff writer Jenny Gold writes about legislation to repeal this exemption. "With comprehensive health care legislation foundering in Congress, the House is turning to a narrower piece of legislation that lawmakers hope has widespread, populist appeal: repealing the antitrust exemption for health and medical liability insurers.
Althea Technologies, Inc., a leading provider of development and manufacturing services for biopharmaceutical products announced the addition of customized Formulation Development to the company's platform of services, which will be overseen by the newly appointed Dr. James Matsuura, Director of Formulation Development.
CryoLife, Inc., an implantable biological medical device and cardiovascular tissue processing company, announced today its results for the second quarter of 2010. Revenues for the second quarter increased 4 percent to a second quarter record of $29.3 million compared to $28.2 million for the second quarter of 2009. Net income for the second quarter of 2010 was $2.9 million, or $0.10 per basic and fully diluted common share, compared to $2.5 million, or $0.09 per basic and fully diluted common share, for the second quarter of 2009.
› Verified 9 days ago
News Archive
Major depression, which afflicts one in six people at some point in their life, is the leading global cause of disability - surpassing cardiovascular and respiratory diseases, cancer and HIV/AIDS combined.
BioCancell, a developer of anti-cancer drugs, announced success in attaining the goals of its Phase I/IIa clinical trial of BC-819 as a treatment for pancreatic cancer, which demonstrated an excellent safety profile and preliminary efficacy.
Kaiser Health News staff writer Jenny Gold writes about legislation to repeal this exemption. "With comprehensive health care legislation foundering in Congress, the House is turning to a narrower piece of legislation that lawmakers hope has widespread, populist appeal: repealing the antitrust exemption for health and medical liability insurers.
Althea Technologies, Inc., a leading provider of development and manufacturing services for biopharmaceutical products announced the addition of customized Formulation Development to the company's platform of services, which will be overseen by the newly appointed Dr. James Matsuura, Director of Formulation Development.
CryoLife, Inc., an implantable biological medical device and cardiovascular tissue processing company, announced today its results for the second quarter of 2010. Revenues for the second quarter increased 4 percent to a second quarter record of $29.3 million compared to $28.2 million for the second quarter of 2009. Net income for the second quarter of 2010 was $2.9 million, or $0.10 per basic and fully diluted common share, compared to $2.5 million, or $0.09 per basic and fully diluted common share, for the second quarter of 2009.
› Verified 9 days ago
Manc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 4705 Towne Ctr, Ste. 201, Saginaw, MI 48604 Phone: 989-799-2770 Fax: 989-799-2737 | |
Cope Personal Developmental Center Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 100 S Jefferson Ave Ste 104, Saginaw, MI 48607 Phone: 989-752-6319 Fax: 989-752-0895 | |
Mind Body- Eft Thearpy Pllc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 2438 Gatesboro Dr W, Saginaw, MI 48603 Phone: 989-274-4006 | |
Dahlia Therapy Pllc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 3854 Dale Rd, Saginaw, MI 48603 Phone: 989-891-7854 | |
Saginaw Psychological Services Inc. Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 2100 Hemmeter Rd, Saginaw, MI 48603 Phone: 989-799-2100 Fax: 989-799-2637 | |
Saginaw Psychological Services Inc. Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 2100 Hemmeter Rd, Saginaw, MI 48603 Phone: 989-799-2100 Fax: 989-799-2637 | |
Mind Body-eft Therapy Pllc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 2438 Gatesboro Dr W, Saginaw, MI 48603 Phone: 989-274-4006 |